Sepha

An overview of Sepha's VisionScan technology in detecting integrity breaches in a range of pharmaceutical blister package types using non-destructive methods compared to traditional blue-dye testing.

“A new whitepaper into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment. The whitepaper was conducted by a leading packaging expert from the University of Ulster, Professor Dorian Dixon. In particular the study found that the laser based Blisterscan, manufactured in the UK by Sepha, was capable of detecting 15% more product defects than traditional blue dye test methods used by the majority of the pharmaceutical market. In the global pharmaceutical blister packaging market, valued at over $40 billion per annum, quality control is paramount and a 15% difference in the ability to detect if a product is sealed correctly or not is significant.”